Cellular Expression of Alphaherpesvirus gD Interferes with Entry of Homologous and Heterologous Alphaherpesviruses by Blocking Access to a Shared gD Receptor  by Geraghty, Robert J. et al.
a
t
o
m
s
a
c
v
u
c
a
v
p
d
U
S
Virology 268, 147–158 (2000)
doi:10.1006/viro.1999.0157, available online at http://www.idealibrary.com onCellular Expression of Alphaherpesvirus gD Interferes with Entry of Homologous and
Heterologous Alphaherpesviruses by Blocking Access to a Shared gD Receptor
Robert J. Geraghty, Cheryl R. Jogger, and Patricia G. Spear1
Department of Microbiology–Immunology, Northwestern University Medical School, Chicago, Illinois 60611
Received September 18, 1999; returned to author for revision November 10, 1999; accepted December 16, 1999
Several human and animal alphaherpesviruses can enter cells via human herpesvirus entry mediator C (HveC), a receptor
for viral glycoprotein D (gD). In previous studies with cells expressing unknown entry mediators, cellular expression of
alphaherpesvirus gD was shown to inhibit entry of the homologous virus and sometimes also of heterologous alphaherpes-
viruses. To investigate the mechanism of gD-mediated interference and the basis for cross-interference among alphaher-
pesviruses, HveC was expressed in cells as the sole entry mediator, in the presence or absence of one of the gDs encoded
by herpes simplex virus type 1, pseudorabies virus, or bovine herpesvirus type 1. Cells expressing HveC alone were highly
susceptible to entry of all three viruses, whereas cells coexpressing HveC and any one of the gDs were at least partially
resistant to infection by each virus. Coexpression of gD with HveC did not cause reduced levels of cell-surface HveC but the
HveC had reduced ability to bind to exogenous gD. Coimmunoprecipitation experiments revealed that HveC was complexed
with gD in lysates of cells expressing both. Thus, cellular expression of gD can interfere with alphaherpesvirus entry by
blocking ligand-binding sites of the gD receptor(s) used for entry and cross-interference can occur because different forms
of alphaherpesvirus gD can compete for shared entry receptors. © 2000 Academic Press
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Expression of the virion envelope glycoprotein D (gD)
is limited to the alphaherpesvirus subfamily of the her-
pesvirus family. All alphaherpesviruses studied to date,
except varicella-zoster virus, express some form of gD.
New findings with herpes simplex virus types 1 and 2
(HSV-1 and HSV-2) demonstrate that viral gD binds to
specific cell-surface receptors to determine which cell
types the viruses can enter (Cocchi et al., 1998; Geraghty
et al., 1998; Krummenacher et al., 1998; Montgomery et
l., 1996; Warner et al., 1998; Whitbeck et al., 1997). Thus,
his glycoprotein is an important determinant of the biol-
gy of these viruses, which typically cause lesions on
ucosal surfaces and spread to the peripheral nervous
ystem to establish latent infections in neurons but can
lso cause severe central nervous system disease. Be-
ause animal alphaherpesviruses such as pseudorabies
irus (PRV) and bovine herpesvirus type 1 (BHV-1) can
se a subset of the human gD receptors for entry into
ells (Cocchi et al., 1998; Geraghty et al., 1998; Warner et
l., 1998), it seems likely that the gDs encoded by these
iruses also bind to the receptors and to homologous
orcine and bovine receptors.
There are similarities among these alphaherpesvi-
1 To whom correspondence and reprint requests should be ad-
ressed at the Department of Microbiology–Immunology, Northwesternm
r
niversity Medical School, 320 E. Superior, Searle Bldg., Mail Code
213, Chicago, IL 60611. Fax: (312) 503-1339. E-mail: p-spear@nwu.edu.
147uses in viral and cellular requirements for entry (Met-
enleiter, 1995; Spear, 1993). Binding of these viruses to
ells is usually mediated by interactions of viral gC, and
erhaps also gB, with heparan sulfate chains on cell-
urface proteoglycans (Herold et al., 1991, 1994; Metten-
eiter et al., 1990; Okazaki et al., 1991). Then, gD can bind
o any one of several specific cell-surface receptors
Cocchi et al., 1998; Geraghty et al., 1998; Krummenacher
t al., 1998; Montgomery et al., 1996; Warner et al., 1998;
hitbeck et al., 1997). The gD–receptor interaction trig-
ers penetration of virus, which occurs by fusion of the
iral envelope with a cell membrane and requires the
oncerted action of four viral glycoproteins, gB, gD, gH,
nd gL (for reviews see Mettenleiter, 1995; Spear, 1993;
ikoo et al., 1995). Thus, efficient entry of the gD-express-
ng alphaherpesviruses into cells depends on the cell-
urface expression of (i) heparan sulfate, a carbohydrate
omponent of ubiquitous cell-surface proteoglycans, and
ii) gD-binding receptors, which probably have a more
imited distribution.
Five distinct gD receptors capable of mediating entry
f HSV-1, HSV-2, PRV, or BHV-1 have been identified to
ate. They include four human cell-surface glycopro-
eins, designated herpesvirus entry proteins A–D (HveA,
veB, HveC, and CD155-HveD). HveA (officially named
NFRSF14) is a member of the tumor necrosis factor
eceptor family and mediates the entry of most strains of
SV-1 and HSV-2 except for HSV-1 strains with certain
utations in gD (amino acid substitutions at position 27,
eferred to here as Rid mutations) (Montgomery et al.,
0042-6822/00 $35.00
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148 GERAGHTY, JOGGER, AND SPEAR1996). HveB and HveC [also known as poliovirus recep-
tor-related proteins 2 and 1 (Eberle´ et al., 1995; Lopez et
al., 1995) or nectin 2 and 1 (Takahashi et al., 1999),
respectively] are members of the immunoglobulin super-
family and, along with the poliovirus receptor (Mendel-
sohn et al., 1989) (designated CD155-HveD), form a
group of related proteins that mediate alphaherpesvirus
entry (Cocchi et al., 1998; Geraghty et al., 1998; Warner et
al., 1998). Expression of HveB in normally resistant cells
renders these cells susceptible to entry of HSV-1 strains
with Rid mutations in gD, as well as HSV-2 and PRV
(Warner et al., 1998). HveC mediates the entry of all
strains of HSV-1, HSV-2, PRV, and BHV-1 tested (Geraghty
et al., 1998). An alternatively spliced isoform of HveC has
also been shown to mediate entry of HSV-1, HSV-2, and
BHV-1 (Cocchi et al., 1998). CD155-HveD mediates the
entry of PRV and BHV-1 but has no activity for HSV-1 or
HSV-2 (Geraghty et al., 1998). Evidence that these cell-
surface proteins are gD receptors comes from findings
that (i) alterations in gD can influence receptor usage
(Montgomery et al., 1996; Warner et al., 1998), (ii) purified
soluble forms of HveA and HveC bind directly to recom-
binant HSV-1 or HSV-2 gD in vitro (Krummenacher et al.,
1998; Whitbeck et al., 1997), and (iii) antibodies specific
for HSV gD but not other envelope glycoproteins can
block the binding of soluble receptors to HSV-1 virions
(Krummenacher et al., 1998; Nicola et al., 1998). Mouse
forms of HveA, HveB, and HveC have also been shown to
mediate entry of one or more of the alphaherpesviruses
mentioned above, with slight differences in specificity
(Shukla et al., 1999a; Shukla and Spear, manuscript in
preparation). Nonhuman primate cells probably also ex-
press receptors that can mediate the entry of more than
one alphaherpesvirus. HSV-1 and PRV were shown to
compete for sites necessary for entry into Vero cells,
provided the virions contained gD (Lee and Fuller, 1993).
The fifth gD receptor is a specific site or set of sites
generated in heparan sulfate by the action of specific
glucosaminyl 3-O-sulfotransferases (Shukla et al.,
1999b). In the absence of all the entry mediators de-
scribed above (HveA-D), resistant cells can be made
susceptible to HSV-1 entry, but not entry of HSV-2, PRV, or
BHV-1, by expression of one of these sulfotransferases,
which modify heparan sulfate so that gD can bind.
Expression of HSV-1, HSV-2, PRV, or BHV-1 gD in nor-
mally susceptible cells can render the cells resistant to
infection by the homologous alphaherpesvirus and het-
erologous alphaherpesviruses, although reciprocal
cross-interference was not always observed (Cam-
padelli-Fiume et al., 1988; Chase et al., 1989, 1990, 1993;
Dasika and Letchworth, 1999; Dean et al., 1995; Johnson
and Spear, 1989; Petrovskis et al., 1988; Tikoo et al.,
1990). This gD-mediated interference was postulated to
occur through a gD-receptor interaction that sequesters
receptor within the cell, such that it is inaccessible to
added virus, in a manner analogous to envelope glyco-protein-mediated interference observed in retroviruses
(Delwart and Panganiban, 1989; Jabbar and Nayak, 1990;
Kawamura et al., 1989; Stevenson et al., 1988). An alter-
native mechanism proposed for gD-mediated interfer-
ence is an interaction between cell-associated gD and
gD in virions that blocks entry (Campadelli-Fiume et al.,
1990). In the cited studies gD-mediated interference was
investigated in cells that express unidentified gD recep-
tors and possibly multiple entry receptors.
Aims of this study were to determine whether cross-
interference among alphaherpesviruses could be ob-
served when a single shared entry receptor, HveC, was
coexpressed with different alphaherpesvirus gDs and
whether gD-mediated interference could be explained by
interactions of cell-associated gD with HveC. We show
here that each alphaherpesvirus gD tested interfered
with HveC-mediated entry of both homologous and het-
erologous viruses. The degree of interference depended
on the source of gD. In every case HveC was expressed
on the surfaces of cells coexpressing gD but the HveC
had reduced receptor activity as evidenced by reduced
ability to bind exogenous gD. Coimmunoprecipitation
experiments demonstrated an interaction between HveC
and HSV-1 gD. We conclude that gD-mediated interfer-
ence can result from cellular gD–receptor interactions
that block binding of receptor to virion gD. Cross-inter-
ference can be accounted for by ability of different al-
phaherpesviruses to use a shared gD receptor, such as
HveC, for entry and to express forms of gD that compete
for access to the receptor.
RESULTS
Cellular expression of alphaherpesvirus gD interferes
with HveC-mediated entry of homologous and
heterologous alphaherpesviruses
Chinese hamster ovary (CHO) cells are resistant to the
entry of HSV-1, Rid mutants of HSV-1, PRV, and BHV-1, but
become susceptible to entry of all these viruses when
HveC is expressed. This makes it possible to test the
ability of various members of the alphaherpesvirus gD
family to interfere with viral entry via a single defined
receptor, by comparing the susceptibility of cells ex-
pressing HveC alone and cells expressing both HveC
and gD to entry of several alphaherpesviruses. The
CHO-K1 cells were transfected with an HveC-expressing
plasmid mixed in a 1:4 molar ratio with one of the gD-
expressing plasmids listed in Table 1 or with control
plasmid. The transfected cells were then inoculated with
serial dilutions of HSV-1(KOS), HSV-1(KOS)Rid1,
PRV(Kaplan), and BHV-1(Cooper) recombinants that ex-
press b-galactosidase upon entry into cells. As shown in
Fig. 1, cells expressing HveC and any of the alphaher-
pesvirus gDs were less susceptible to infection than
cells expressing HveC without gD. The various forms of
gD displayed reproducible differences in ability to inter-
a149BLOCKADE OF HERPESVIRUS ENTRY BY gDfere with HveC-mediated entry. Cells expressing HveC
and HSV-1(KOS)Rid1 gD were invariably the least sus-
ceptible to alphaherpesvirus entry (maximal interfer-
ence), regardless of the challenge virus, while cells ex-
pressing HveC and BHV-1 gD were the most susceptible
to alphaherpesvirus entry (minimal interference).
The inhibitory effect of gD expression on HveC-medi-
ated viral entry was dependent on the amount of gD-
expressing plasmid used and presumably on the level of
gD expression in relation to HveC expression, i.e., more
inhibition was observed at a 1:4 ratio of HveC- to gD-
expressing plasmids than at a 1:1 ratio when the total
amounts of plasmid DNA and HveC-expressing plasmid
were kept constant (data not shown). Expression of gD
with or without HveC had no inhibitory effect on the
ability of viruses in general to enter CHO-K1 cells. For
example, cells transfected with mixtures of plasmids as
described in Fig. 1 or with gD-expressing plasmids alone
were equivalently susceptible to entry of a Sindbis virus
recombinant that expresses green fluorescent protein
(flow cytometry revealed that about 30% of cells were
fluorescent in all cases, data not shown). Finally, the
inhibitory effect of gD depended on the entry receptor
expressed and whether the cell-associated gD would be
expected to interact with the entry receptor. HveB medi-
ates entry of Rid mutants of HSV-1(KOS) but not the
wild-type virus. When CHO-K1 cells were cotransfected
with a plasmid expressing HveB and plasmids express-
ing mutant or wild-type gD or control plasmid, entry of
HSV-1(KOS)Rid1 was inhibited in cells expressing HSV-
1(KOS)Rid1 gD but not in cells expressing wild-type
HSV-1 gD (Fig. 2). Because wild-type HSV-1 gD interferes
with HveC-mediated but not HveB-mediated entry, it
seems likely that the effects observed in Fig. 1 are
TABLE 1
Plasmids Expressing Entry Receptors or Alphaherpesvirus gDa
Plasmidb Protein expressed
MW20 HveB
BG38 HveC
CJ4 HveC-HA
BG58 BHV-1 gD
CJ1 HSV-1(KOS)Rid1 gD
CJ3 HSV-1(Patton) gDc
CMV gD PRV gD
pcDNA3 —
a Construction of plasmid or reference for plasmid under Materials
nd Methods.
b All plasmids contain the human cytomegalovirus immediate early
promoter for efficient expression in eukaryotic cells.
c Referred to as wild-type HSV-1 gD in the text. The Patton and KOS
forms of gD differ by one amino acid in the cleaved signal sequence
and therefore the mature form of HSV-1(Patton) gD is identical to
HSV-1(KOS) gD.related to specific gD-receptor interactions and are not
due to any nonspecific toxic effects of gD.Expression of HveC and gD in cotransfected cells
and on cell surfaces
It is generally accepted that, in cells transfected with
mixtures of plasmids, the cells will take up and express
either all plasmids or none. To determine whether this
was true under the experimental conditions used here,
two experiments were done. First, CHO-K1 cells were
cotransfected with plasmids expressing HveC and HSV-1
gD at a 1:4 molar ratio, under exactly the same condi-
tions used for the interference experiments, and ana-
lyzed by two-color immunofluorescence. Both before and
after fixation, samples of the transfected cells were
stained with polyclonal anti-HveC (chicken) and anti-gD
(rabbit) antibodies using fluorescein-labeled and rho-
damine-labeled secondary antibodies, respectively. Fig-
ure 3A demonstrates that about 50% of the transfected
cells expressed proteins encoded by the plasmids on
their surfaces and that cells expressing HveC coex-
pressed gD and vice versa. Examination of fixed cells
suggested that HveC and gD were largely colocalized
inside the cells. An example is shown in Fig. 3B. Second,
FIG. 1. Expression of alphaherpesvirus gD interferes with alphaher-
pesvirus entry via HveC. CHO-K1 cells were transfected with plasmids
expressing HveC (pBG38) and an alphaherpesvirus gD (see Table 1) at
a molar ratio of 1:4, HveC (pBG38) and control plasmid DNA (pcDNA3)
at a molar ratio of 1:4, or control plasmid (pcDNA3). Twenty-four hours
later the cells were replated in 96-well plates and the next day exposed
to HSV-1(KOS), HSV-1(KOS)Rid1, PRV(Kaplan), or BHV-1(Cooper) recom-
binants expressing b-galactosidase. Six hours after inoculation, cells
were lysed and b-galactosidase activity was determined as a measure
of virus entry. The assays were performed in triplicate and repeated
three times with similar results. The mean values plus standard devi-
ations for a representative experiment are depicted. Transfections with
alphaherpesvirus gD plasmids (see Table 1) plus control plasmid
(pcDNA3) at a molar ratio of 4:1 yielded results equivalent to transfec-
tion with control plasmid (pcDNA3) alone and are not shown. PFU,
plaque-forming units.
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tive assessments. Dead cells were identified by pro-
pidium iodide staining and excluded from the analysis of
live cells stained with anti-HveC and anti-gD antibodies.
Four cell populations, transfected with control plasmid
alone, HveC-expressing plasmid plus control plasmid, a
plasmid expressing HSV-1(KOS)Rid1 gD plus control
plasmid, or HveC-expressing plasmid plus the Rid1 gD-
expressing plasmid, were analyzed. As expected, cells
stained with anti-HveC but not anti-gD antibodies were
detected in the population transfected with the HveC-
expressing plasmid plus control plasmid and cells
stained with anti-gD but not anti-HveC antibodies were
detected in the population transfected with the gD-ex-
pressing plasmid plus control plasmid. Few if any singly
labeled cells were detected in the population transfected
with both the HveC- and the gD-expressing plasmids.
The percentages of cells stained with anti-HveC antibod-
ies were similar, about 15–20%, whether or not gD was
coexpressed. These results indicate that cotransfected
cells expressed both proteins on cell surfaces and that
coexpression did not abrogate cell-surface expression of
either.
To determine the levels of HveC and alphaherpesvirus
gD expressed on the surfaces of cotransfected cells, an
ELISA assay on live cells (CELISA) (Walker et al., 1992)
was performed in parallel with the infectivity assays
described in Fig. 1. In the CELISA assay, transfected cells
were incubated with either polyclonal chicken antibodies
FIG. 2. Interference depends on specific gD-receptor interaction.
CHO-K1 cells were transfected with plasmids expressing HveB
(pMW20) and wild-type or Rid1 HSV gD (pCJ3 or pCJ1) at a molar ratio
of 1:4, HveB (pMW20) and control plasmid (pcDNA3) at a molar ratio of
1:4, control plasmid (pcDNA3) and gD-expressing plasmid (pCJ3 or
pCJ1) at a molar ratio of 1:4, or control plasmid (pcDNA3). The cells
were inoculated with an HSV-1(KOS)Rid1 recombinant expressing
b-galactosidase, HSV-1(KOS)Rid1tk12. The infections were performed
in triplicate and repeated three times with similar results. The mean
values plus standard deviations for a representative experiment are
depicted. Transfections with wild-type HSV-1 or HSV-1(KOS)Rid1 gD
plasmids, pCJ3 or pCJ1, plus control plasmid (pcDNA3) at a molar ratio
of 4:1 yielded results equivalent to transfection with control plasmid
(pcDNA3) alone and are not shown.against HveC or an anti-gD antibody before fixation to
ensure detection of cell-surface protein. Binding of theprimary antibodies was detected after fixation by apply-
ing biotinylated secondary antibodies, streptavidin-con-
jugated horseradish peroxidase, and substrate. Figure
4A shows that cells expressing HveC and alphaherpes-
virus gD displayed approximately the same levels of
HveC as cells expressing HveC alone. The levels of
cell-surface HveC expression were apparently unaf-
fected even on cells coexpressing HveC and HSV-1-
(KOS)Rid1 gD, despite the virtual elimination of alphaher-
pesvirus entry activity observed in replicate cultures of
cells (Fig. 1). Also, cells expressing a particular alpha-
herpesvirus gD displayed equivalent levels of cell-sur-
face gD in the presence or absence of HveC expression
(Fig. 4B).
A control experiment revealed that the CELISA assay
for detection of HveC gave signals proportional to the
actual level of HveC expression on cell surfaces.
CHO-K1 cells were cotransfected with HveC-expressing
plasmid and control plasmid (to mimic the conditions
used in our interference experiments) or were trans-
fected with control plasmid alone. The two cell popula-
tions were then mixed in variable proportions, keeping
the total cell number constant, and replated in replicate
96-well dishes. One set of cultures was used for an
anti-HveC CELISA assay and the other for challenge with
HSV-1(KOS)Rid1 virus to quantitate viral entry activity.
The results shown in Fig. 5 demonstrate that expression
of cell-surface HveC and viral entry activity in the mixed-
cell populations were both roughly proportional to the
numbers of HveC-expressing cells added. Therefore, if
the resistance to viral entry of cells coexpressing HveC
and gD (Fig. 1) were due to significant reductions in
amounts of HveC on cell surfaces, we would have
detected these reductions in the experiment shown in
Fig. 4.
Receptor activity of cell-surface HveC in the presence
or absence of coexpressed gD
Because of the reduced ability of alphaherpesviruses
to enter cells coexpressing gD and HveC, despite de-
tectable cell-surface expression of HveC, an assay was
devised to assess the gD-binding activity of cell-surface
HveC. This gD-binding assay was performed on replicate
cultures of transfected cells prepared at the same time
as those used for the experiments shown in Figs. 1 and
4. A gD:Fc hybrid protein containing the extracellular
domain of HSV-1(KOS) gD fused to the rabbit IgG Fc
region was used as a source of soluble gD to test the
binding activity of cell-surface HveC in the presence or
absence of gD coexpression. The purified gD:Fc hybrid
protein was shown by ELISA to contain domains recog-
nized by gD monoclonal antibodies as well as rabbit-Fc-
specific antibodies (A. Fridberg, R. J. Geraghty, B. Lum,
and P. G. Spear, manuscript in preparation). Transfected
cells were incubated with the gD:Fc hybrid protein and
vice ve
151BLOCKADE OF HERPESVIRUS ENTRY BY gDthen washed, fixed, and incubated with a detection sys-
tem for quantitating the amount of rabbit Fc bound. As
shown in Fig. 6, cells expressing only HveC bound gD:Fc
at a much higher level than cells coexpressing HveC and
each of the alphaherpesvirus gDs. Cells transfected with
control plasmid alone failed to bind the gD:Fc hybrid
protein. Therefore, although HveC expression was un-
changed on the surfaces of cells coexpressing HveC and
gD, compared to cells cotransfected with HveC and
control plasmid, cell-surface HveC had significantly re-
duced ability to interact with exogenous gD.
Complex formation between cell-associated gD and
HveC
To detect an interaction between HveC and cell-asso-
FIG. 3. Cells cotransfected with gD-expressing and HveC-expressin
CHO-K1 cells were cotransfected, at a molar ratio of 1:4, with plasmids
later, the cells were replated onto coverslips. The next day, live cells w
serum R7 at 4°C (A) or the cells were fixed with acetone and exposed
incubation with primary antibodies, the live cells were fixed with ac
TRITC-conjugated secondary antibodies, illuminated to detect the FITC
Zeiss fluorescence Axioscope. Cells expressing either HveC alone or gD
that the FITC signal was not detectable using TRITC illumination andciated gD, a coimmunoprecipitation experiment was per-
formed using lysates of cells expressing a tagged ver-sion of HveC (HveC-HA) alone, HSV-1(KOS)Rid1 gD
alone, or the two proteins together. Control experiments
showed that HveC-HA was indistinguishable from au-
thentic HveC in viral entry activity and susceptibility to
gD-mediated interference (data not shown). The trans-
fected cells were lysed and immunoprecipitations were
performed with the anti-HSV gD serum R7. The immuno-
precipitates were electrophoresed, the proteins trans-
ferred to nitrocellulose, and the Western blots incubated
either with a monoclonal antibody to HSV-1 gD, to deter-
mine the efficiency of the gD immunoprecipitation, or
with an anti-HA monoclonal antibody to detect an inter-
action between HveC-HA and gD (Materials and Meth-
ods). The results depicted in Fig. 7 demonstrate that
gD-specific antibodies coimmunoprecipitated HveC-HA
ids display both HveC and gD on cell surfaces and within the cells.
sing HveC (pBG38) and wild-type HSV-1 gD (pCJ3). Twenty-four hours
posed to chicken anti-HveC polyclonal antibodies and rabbit anti-gD
i-HveC polyclonal antibodies and anti-gD serum R7 at 37°C (B). After
All cells were then incubated with appropriate FITC-conjugated and
ITC fluorescence or viewed under phase-contrast illumination using a
were also viewed using illumination to detect FITC or TRITC to ensure
rsa.g plasm
expres
ere ex
to ant
etone.
or TR
alonefrom lysates of cells coexpressing HveC-HA and gD but
not from lysates of cells expressing HveC-HA alone or
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152 GERAGHTY, JOGGER, AND SPEARfrom control cells, indicating that complexes containing
HveC and gD formed in cells coexpressing these pro-
teins. Figure 7 also shows that coexpression of HveC
with gD influences the posttranslational processing of
gD. The two bands recognized by anti-gD antibodies
from cells expressing gD alone have been identified as
immature (lower band) and mature forms, which differ in
the stage of processing of N-linked glycans from high
mannose to complex and in presence of O-linked gly-
cans (Johnson and Spear, 1983). The single gD band that
predominates in lysates and immunoprecipitates from
cells coexpressing HveC with gD could represent a form
of gD without O-linked glycans or some other modified
form of gD. Presumably the changes in posttranslational
processing of gD caused by HveC coexpression are not
accompanied by reduced transport of gD to the cell
FIG. 4. Resistant cells express HveC and gD on their surfaces.
eplicate cultures of the CHO-K1 cells transfected for experiments
s shown in Fig. 1 were replated in 96-well plates. Twenty-four
ours later, CELISA assays were performed. Live cells were ex-
osed to primary antibodies and then washed and fixed. Binding of
he primary antibodies was detected by use of biotinylated second-
ry antibodies and streptavidin-conjugated horseradish peroxidase.
hicken antibodies were used to detect HveC (A) and, in replicate
ultures, various antibodies were used to detect the different alpha-
erpesvirus gDs (B). Peroxidase activity was assayed as a measure
f HveC or gD antigen on the cell surface. Within each experiment,
ll values were expressed as a percentage of the value obtained for
he HveC/control plasmid transfection (values range from 0.134 to
.429 OD 370 nm) (A) or gD/control plasmid transfection (B) for each
orm of gD separately (gD/control values range between 0.5 and 0.9
D370 nm). The experiments were performed three times and the
ean values plus standard deviations for the combined results are
epicted.surface (Figs. 3 and 4). Interestingly, the HveC that co-
precipitated with gD appears to be enriched for higher
m
amolecular weight forms of HveC-HA, possibly the most
highly glycosylated forms.
DISCUSSION
Results presented here demonstrate that gD-mediated
interference with herpesvirus infection can be explained
by an interaction between cell-associated gD and avail-
able gD-binding receptors such that the receptors are
not accessible to virion-associated gD even if they are
present on the cell surface. We expected to find a se-
questration of gD receptors inside the cell (which may
occur to some extent and in some cell types) as a result
of gD coexpression but found instead that the amount of
HveC present on cell surfaces was not significantly re-
duced, if at all, when gD was also expressed. The ability
of cell-surface HveC to bind to exogenous soluble gD
was severely reduced, however, indicating that cell-as-
sociated gD bound to cell-surface HveC so as to occlude
the binding sites for soluble exogenous gD or virion-
associated gD. A physical association of HveC with gD
was demonstrated by the coimmunoprecipitation of
FIG. 5. Cell-surface expression of HveC and viral entry activity in
mixed-cell populations. Mixed populations of cells containing an in-
creasing percentage of HveC-expressing cells were inoculated with
HSV-1(KOS)Rid1tk12 (circles) or tested for cell-surface expression of
HveC (squares). CHO-K1 cells were transfected with HveC-expressing
plasmid (pBG38) and control plasmid at a 1:4 molar ratio or with control
plasmid (pcDNA3). Twenty-four hours later, the two transfected cell
populations were mixed in various proportions and replated in 96-well
dishes at 8 3 104 cells/well. To test the susceptibility to HSV-1 infection,
he next day the cells were incubated with an HSV-1(KOS)Rid1 recom-
inant expressing b-galactosidase at a range of concentrations and
b-galactosidase activity was quantitated as a measure of viral entry.
The results depicted were for 5 3 105 PFU/well and in the linear range
when virus dose was plotted against b-galactosidase activity. The
ssays were performed in triplicate and repeated two times with
imilar results. The mean values plus standard deviations for a repre-
entative experiment are depicted. To quantitate the levels of HveC
xpression, an anti-HveC CELISA was performed as for Fig. 4. Five
quivalent wells per sample were analyzed in each experiment and two
ndependent experiments were performed with similar results. The
ean values plus standard deviations of a representative experiment
re depicted.
153BLOCKADE OF HERPESVIRUS ENTRY BY gDHveC with gD. One implication of these findings is that
HveC–gD interactions required for interference may be
similar or identical to those required for viral entry. Thus,
an alphaherpesvirus that cannot use one of the gD re-
ceptors for entry, due to failure to bind the receptor,
should encode a form of gD that has little or no ability to
interfere with use of this receptor by other viruses. Con-
sistent with this prediction, wild-type HSV-1(KOS) gD
interferes with entry of viruses via HveA (Mauri et al.,
1998) or HveC but not HveB, whereas mutant HSV-1
(KOS)Rid1 gD can interfere with entry via HveB (Fig. 2).
The basis for cross-interference among alphaherpes-
viruses can be the ability of these viruses to use the
same gD receptor for entry. Each form of alphaherpes-
virus gD tested was able to interfere with entry of the
homologous and heterologous viruses, presumably be-
cause the only gD receptor available was HveC, which
can mediate entry of all the viruses used. In previous
studies nonreciprocal cross-interference was observed.
For example, bovine cells expressing BHV-1 gD were
resistant to entry of both BHV-1 and PRV, whereas the
same cells expressing PRV gD were resistant to PRV
entry but not BHV-1 entry (Chase et al., 1990, 1993). A
possible explanation is that multiple gD receptors were
expressed in the bovine cells, some of which mediate
entry of both BHV-1 and PRV and at least one of which
mediates entry of BHV-1 only.
FIG. 6. HveC expressed on the surfaces of gD-expressing cells has
reduced ability to bind exogenous gD. Replicate cultures of CHO-K1
cells transfected for experiments as shown in Fig. 1 were replated in
96-well plates. The next day the cells were exposed to gD:Fc, washed,
fixed with formaldehyde and glutaraldehyde, and incubated with bio-
tinylated secondary antibodies followed by streptavidin-conjugated
horseradish peroxidase. Peroxidase activity was assayed as a mea-
sure of gD:Fc binding to the cell surface. Within each experiment, all
values were made relative to the value obtained for the HveC/control
plasmid cotransfection (HveC/control values ranged between 0.09 and
0.4 OD 370 nm). Cells transfected to express each of the gDs alone
were included in these experiments. No significant binding of gD:Fc to
cells expressing only gD was detected (data not shown). The experi-
ments were performed three times and the mean values plus standard
deviations for the combined results are depicted.The fact that interference was observed with all com-
binations of gD and challenge virus tested indicates thateach form of alphaherpesvirus gD interacts with overlap-
ping domains of HveC. We suggest that the relative
degree of interference observed with each form of gD
reflects the relative affinity of its interaction with HveC.
This proposed correlation is supported by findings that a
soluble form of HSV-1(KOS)Rid1 gD binds to soluble
HveC with higher affinity than does a similar form of
wild-type HSV-1(KOS) gD (Krummenacher et al., 1999). In
addition, the different forms of gD could be ranked ac-
cording to their interference activity and this ranking was
the same regardless of challenge virus (Fig. 1). Finally,
the virus encoding gD with least interference activity
(BHV-1) was also most sensitive to interference regard-
less of the form of gD expressed, indicating that the
BHV-1 form of gD competed poorly with all forms of
cell-associated gD for receptor.
Interestingly, HSV-1 and PRV gDs had nearly equiva-
lent interference activities despite only 27% sequence
identity. On the other hand, the wild-type and Rid1 forms
of HSV-1 gD differ by only one amino acid and yet differ
in interference activity. The fact that several divergent
and similar forms of gD can apparently compete for
binding sites on human HveC should facilitate identifica-
tion of the structural features of gD required for the
binding.
Interference assays provide a powerful tool for char-
acterizing the interaction between viral glycoproteins
and entry receptors and could be used to identify the
FIG. 7. Coexpression of HveC and HSV-1 gD results in an HveC-gD
interaction. PEAK cells (Edge BioSystems) were transfected, at a molar
ratio of 1:1, with plasmids expressing HveC-HA (pCJ4) and Rid1 gD
(pCJ1), HveC-HA-expressing plasmid (pCJ4) and control plasmid
(pcDNA3), Rid1 gD-expressing plasmid (pCJ1) and control plasmid
(pcDNA3), or control plasmid (pcDNA3) alone. Forty-eight hours later,
the cells were detached, lysed for immunoprecipitation with rabbit
polyclonal anti-HSV gD serum R7, or lysed with sample buffer and
analyzed by SDS–PAGE. After electrophoresis, the separated proteins
were transferred to nitrocellulose and Western blot analysis was per-
formed to detect gD (anti-gD monoclonal antibody DL6) or HveC-HA (rat
anti-HA monoclonal antibody) in the gD immunoprecipitates or in the
cell lysates. After incubation with the primary antibodies, the mem-
branes were incubated with appropriately conjugated secondary anti-
body and visualized via enhanced chemiluminescence.
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154 GERAGHTY, JOGGER, AND SPEARviral ligands for entry receptors in cases in which the
virus expresses multiple candidates for such ligands.
Interference assays can also be used to determine
whether different viruses can use the same receptor for
entry, as has been well-documented for retroviruses
(Kewalramani et al., 1992; Miller, 1996; Sommerfelt and
eiss, 1990). Finally, interference assays provide a facile
eans of characterizing functional domains of the inter-
ering viral protein. Mutations in gD that abrogate inter-
erence activity (without global effects on overall protein
tructure) are likely also to eliminate entry activity, as-
uming that the gD–HveC interactions required for both
ctivities are sufficiently similar.
What is the physiological relevance of envelope gly-
oprotein-mediated interference with viral entry? In the
ase of retroviruses, expression of envelope glycopro-
ein in infected cells prevents superinfection with homol-
gous or related viruses. Since pathogenesis or spread
f these viruses often depends on continued survival and
eplication of productively infected cells, superinfection
xclusion can prevent multiple provirus insertions and
romote cell survival. Retrovirus interference is often
ssociated with reduction in levels of cell-surface recep-
ors, which could aid in release of virus from infected
ells and might also alter normal cell functions depen-
ent on cell-surface expression and accessibility of the
eceptors. In the case of alphaherpesviruses, gD is ex-
ressed only in lytically infected cells and it is not clear
hether superinfection of lytically infected cells occurs
r is of any consequence. It has been postulated that
D-mediated interference is important for efficient
gress and release of infectious virus by preventing
ewly enveloped virus from fusing with membranes of
he virus-producing cell (Campadelli-Fiume et al., 1990;
Johnson and Spear, 1989). It is also possible that inter-
action of gD with its various receptors could alter the
activities of these receptors. Under certain conditions
binding of gD to HveA can prevent binding of HveA to its
natural ligands, members of the tumor necrosis factor
family (Mauri et al., 1998). Recently, HveB and HveC have
been shown to function as homophilic adhesion mole-
cules that localize to intercellular junctions (Takahashi et
al., 1999). The expression of gD within epithelial cells at
the initial site of infection could inhibit the localization of
HveC to these junctions and perhaps affect the junc-
tional integrity. This disruption may aid in the spread of
infectious virus and possibly even facilitate spread of
virus from the initial site of infection to neurons for the
establishment of latency.
MATERIALS AND METHODS
Cells and viruses
CHO-K1 cells were provided by J. Esko (University of
California at San Diego) and were grown as previously
described (Montgomery et al., 1996). The PEAK cells
p
t(Edge Biosystems) were grown in DMEM supplemented
with 10% fetal bovine serum and antibiotics. The b-ga-
lactosidase-reporter viruses used have been described
previously, HSV-1(KOS)tk12 and HSV-1(KOS)Rid1tk12
(Warner et al., 1998), PRVgH2 (Babic et al., 1996) provided
y T. Mettenleiter (Federal Research Centre for Virus
iseases of Animals, Insel Riems, Germany), and BHV-
(Cooper)v4a (Miller et al., 1995) provided by L. Bello
University of Pennsylvania). The HSV strains were prop-
gated on HEp-2 cells and titered on Vero cells, PRVgH2
was propagated and titered on gH-expressing VeroSW78
cells, and BHV-1(Cooper)v4a was propagated and titered
on MDBK cells. Sindbis virus (strain TRSB) expressing
green fluorescent protein (Klimstra et al., 1998) was pro-
vided by W. Klimstra and R. Johnston (University of North
Carolina at Chapel Hill).
Plasmids
All expression plasmids use the human cytomegalo-
virus (CMV) immediate-early promoter for efficient pro-
tein expression in eukaryotic cells. The construction of
the HveC- and HveB-expression plasmids, pBG38 and
pMW20, respectively, has been described (Geraghty et
al., 1998; Warner et al., 1998). A plasmid expressing a
tagged version of HveC (pCJ4) was constructed by am-
plifying the HveC open reading frame (ORF) with the
primers cD3prim (59CACTGCTTACTGGCTTATCG) and
BamHveC (59GCGGATCCGCCACGTACCACTCCTTCT-
TGG), digesting the amplified product with BamHI, and
inserting that fragment into pMN104 (Montgomery et al.,
996) via the BamHI site. The protein expressed by pCJ4
s designated HveC-HA and consists of the entire HveC
RF fused at its carboxy-terminus to the influenza A
emagglutinin (HA) epitope YPYDVPDYA (Wilson et al.,
984). The plasmids expressing the HSV-1(KOS)Rid1 or
ild-type HSV-1 form of gD, pCJ1 or pCJ3, were con-
tructed by excising the gD gene from plasmids pMW13
r pRE4 (Cohen et al., 1988), respectively, via flanking
indIII restriction sites, and inserting the genes into the
indIII site of pcDNA3 (Invitrogen). The plasmid MW13
as provided by M. Warner and constructed by replacing
he gD gene in pRE4 with the Rid1 form of gD taken from
HD32 (Dean et al., 1994) using the AflIII and AccI re-
triction enzyme sites. The PRV gD-expressing plasmid
CMVgD, provided by V. Gerdts (Federal Research Cen-
re for Virus Diseases of Animals), has been described
Gerdts et al., 1997). The BHV-1 gD-expression plasmid,
BG58, was constructed by digesting pMAGD (Fehler et
l., 1992), provided by G. Keil (Federal Research Centre
or Virus Diseases of Animals), with HindIII and AvrII to
solate a fragment containing the gD open reading frame
nd inserting the fragment into the HindIII and XbaI sites
n pcDNA3. The plasmid expressing the gD:Fc fusion
rotein, pBG64, was constructed by isolating the HindIII
o XbaI fragment containing the gD:Fc gene from pBL50
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155BLOCKADE OF HERPESVIRUS ENTRY BY gDand inserting it into the HindIII and XbaI sites in pcDNA3.
The plasmid BL50, provided by B. Lum, contains an ORF
encoding the entire extracellular domain of HSV-1(KOS)
gD up to the SgrAI site at the beginning of the transmem-
brane domain fused to the hinge, CH2, and CH3 regions
of the rabbit IgG heavy chain. To facilitate construction, a
linker region was placed in frame between the gD do-
main and the Fc domain beginning with the 59 CG from
he SgrAI site in gD: 59CGCCGGGTACCGAGCTCGAAT-
CACAAGACCGTTG (the underlined nucleotides repre-
sent the 59 sequences of the Fc region). The Fc region of
the fusion protein was derived from Clone 3-4 provided
by K. Knight (Loyola University Medical Center).
Antibodies and hybrid protein
The chicken polyclonal anti-HveC antibodies were
generated at Aves Laboratories by inoculation of laying
chickens with the extracellular domain of HveC
(HveC346t), provided by G. Cohen and R. Eisenberg
(Krummenacher et al., 1998), and total IgY was purified
from the eggs. The rabbit polyclonal anti-HveB serum
R146 (Warner et al., 1998), the rabbit anti-HSV gD serum
R7 (Isola et al., 1989), the anti-gD monoclonal antibody
DL-6 (Cohen et al., 1986), the anti-PRV gD monoclonal
antibody 6D8MB4 (ATCC), and the anti-BHV-1 gD mono-
clonal antibody 1B8-F11 (ATCC) were provided by G.
Cohen and R. Eisenberg. The rat anti-HA high-affinity
monoclonal antibody was purchased from Boehringer
Mannheim (Cat. No. 1867423). To produce the gD:Fc
protein, PEAK cells were transfected with pBG64 by the
calcium phosphate method (according to the Edge Bio-
systems’ protocol), and the secreted protein was purified
using protein A/G columns (Pierce) following the manu-
facturer’s instructions. The purified gD:Fc protein was
shown to bind specifically to cells transfected to express
HSV-1 gD receptors, including HveA (unpublished), HveC
(this study—Fig. 6), and 3-OST-3-modified heparan sul-
fate (Shukla et al., 1999b), but not to cells devoid of such
receptors. A full description of the properties of this
hybrid protein will be published elsewhere (A. Fridberg,
R. J. Geraghty, B. Lum, and P. G. Spear, manuscript in
preparation).
Interference assay
Subconfluent CHO-K1 cells were transfected with 5 ml
ipofectAMINE reagent and 1.5 mg of plasmid DNA per
well of a 6-well dish according to the manufacturer’s
instructions. The molar ratio of gD plasmid or control
plasmid (pcDNA3) to HveC- or HveB-expressing plasmid
was 4:1. Twenty-four hours later, the cells were replated
into 96-well dishes (approximately 2 3 104 cells per well).
welve to 24 h later, the cells were inoculated with virus
iluted in phosphate-buffered saline (PBS). After 1.5 h,he virus inoculum was removed, and the cells were
reated with 0.1 M citrate buffer (pH 3) and washed threetimes with cell culture medium. Approximately 4.5 h later,
the cells were lysed and b-galactosidase activity was
determined to measure virus entry as described (Mont-
gomery et al., 1996).
Sindbis virus–GFP infections were performed as de-
scribed (Klimstra et al., 1998). Briefly, cells transfected as
above and replated into 24-well dishes were inoculated
for 60 min at 37°C with 3 3 107 PFU in PBS. The
monolayers were washed three times with PBS and
incubated in growth medium for 7 h. The cells were
removed from plates using PBS/4 mM EDTA, washed
with ice-cold growth medium, resuspended in cold
PBS/2% heat-inactivated-calf serum, and analyzed by
flow cytometry to determine the percentage of infected
cells.
CELISA assay and gD:Fc binding assays
CHO-K1 cells were transfected as described above
and, after 24 h, were plated into 96-well dishes (approx-
imately 4 3 104 cells per well). The next day, the cells
were incubated with primary antibodies in 50 ml PBS/3%
SA for 30 min at room temperature at the following
ilutions: polyclonal chicken anti-HveC at 1 mg/ml, poly-
lonal rabbit anti-HveB serum R146 at 1:5000, polyclonal
abbit anti-HSV gD serum R7 at 1:20,000, monoclonal
nti-PRV gD 6D8MB4 ascites fluid at 1:5000, monoclonal
nti-BHV gD 1B8-F11 ascites fluid at 1:1000, and the
D:Fc fusion protein at 1 mg/ml. (The anti-HveC and
nti-HveB sera were preadsorbed against CHO-K1 cells
t room temperature for 15 min before use.) After primary
ncubation, the cells were washed five times with PBS
nd fixed with 100 ml 2% formaldehyde and 0.2% glutar-
ldehyde for 10 min at room temperature. The cells were
ashed three times with PBS/3% BSA and incubated
ith biotinylated secondary antibodies against rabbit
gG (Sigma), mouse IgG (Sigma), or chicken IgY (Vector
aboratories) at a 1:500 dilution in 100 ml PBS/3% BSA for
0 min at room temperature. Following the secondary
ncubation, the cells were washed five times with PBS
nd incubated with AMDEX streptavidin-conjugated
orseradish peroxidase (Amersham) at 1:20,000 dilution
n 100 ml PBS/3% BSA/0.1% Tween 20 for 30 min at room
temperature. Following tertiary incubation, the cells were
washed five times in PBS/0.1% Tween 20 and incubated
with 3,39,5,59-tetramethylbenzidine in phosphate-citrate
buffer as per the manufacturer’s instructions (Sigma). At
various times after addition of substrate, the plates were
read at 370 nm in a Spectra Max 250 ELISA reader.
Immunoprecipitation and Western blot analyses
PEAK cells were transfected with plasmids expressing
HveC-HA (pCJ4) or HSV-1(KOS)Rid1 gD (pCJ1) mixed 1:1
with pcDNA3 or with a mixture of pCJ4 and pCJ1 using
the calcium phosphate transfection method (Edge Bio-
systems). For these experiments, a 1:1 ratio of gD:HveC-
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HA. Forty-eight hours after transfection the cells were
harvested and lysed on ice for 10 min in 1 ml of ice-cold
lysis buffer containing 0.5% Triton X-100, 10% glycerol, 10
mM Tris–HCl, pH 7.5, 145 mM NaCl, 5 mM EDTA, and
aprotinin, leupeptin, and pepstatin each at 10 mg/ml. The
cell lysates were clarified by centrifugation for 15 min at
4°C. The lysates were then precleared with 75 ml of
protein A/G (Pierce) for 1 h at 4°C. At the same time, 75
ml of protein A/G was added to 15 ml of rabbit anti-HSV
gD serum R7, in 1 ml of cold PBS, and incubated at 4°C
for 1 h. The precleared lysate was incubated with the
R7-protein A/G for 1 h at 4°C. The immune complexes
were collected by centrifugation at 11,000 rpm in a mi-
crocentrifuge for 2 min at 4°C. The complexes were
washed three times with lysis buffer over 30 min, boiled
for 4 min in SDS sample buffer containing 100 mM DTT,
and separated on a 10% SDS–polyacrylamide gel. The
proteins were transferred to a nitrocellulose membrane.
The membrane was blocked for 1 h at room temperature
in PBS containing 0.1% Tween 20, 5% milk powder, and
1% BSA. Immunoblots were performed with a 1:5000
dilution of anti-HA monoclonal antibody or a 1:5000 di-
lution of gD monoclonal antibody DL6 in blocking buffer
for 1 h at room temperature. The blots were washed
three times for 10 min in PBS containing 0.1% Tween 20.
Horseradish peroxidase-conjugated anti-rat or anti-
mouse secondary antibodies (Boehringer Mannheim)
were incubated with the blots for 30 min (1:5000 dilution
in blocking buffer). The blots were then washed three
times for 10 min with PBS containing 0.1% Tween 20. The
proteins were visualized by enhanced chemilumines-
cence system following the manufacturer’s protocol (Am-
ersham Pharmacia Biotech).
Immunofluorescence
CHO-K1 cells were transfected as described above
and 24 h later replated onto glass coverslips. Twenty-four
hours later, the cells were stained. For cell-surface im-
munofluorescence, the cells were incubated with both
primary antibodies at 4°C for 45 min, washed 10 times
with cold PBS, and fixed with acetone for 10 min at
220°C. The polyclonal chicken anti-HveC antibodies
were diluted 1:200 in PBS/10% normal goat serum (NGS)
and the anti-gD polyclonal rabbit serum was diluted
1:500 in PBS/10% NGS. After fixation, cells were dried at
room temperature for 5 min, blocked in PBS/10% calf
serum, and incubated with FITC-conjugated and TRITC-
conjugated secondary antibodies prepared in goats
against chicken IgY (Aves Laboratories) and rabbit IgG
(Jackson Laboratories), respectively, at a dilution of 1:80
in PBS/10% NGS, for 30 min at 37°C. Following second-
ary antibody incubation, the cells were again washed 10
times in PBS. For immunofluorescence on permeabilized
cells, the cells were fixed with acetone for 10 min at220°C, dried at room temperature, blocked in PBS/10%
calf serum for 30 min, and incubated with primary anti-
bodies for 30 min at 37°C. The polyclonal anti-HveC
antibodies were diluted 1:500 and the polyclonal anti-gD
serum R7 was diluted 1:1000 in PBS/NGS. After incuba-
tion with primary antibodies, the cells were washed 10
times with PBS and incubated with secondary antibodies
as described above. All coverslips were mounted on
slides using mounting solution (40 mM Tris, pH 8.0, 75%
glycerol, 0.1% p-phenylenediamine) and viewed using a
Zeiss fluorescence Axioscope.
Flow cytometry
CHO-K1 cells were transfected as described above
and after 48 h detached with PBS/4 mM EDTA. Approx-
imately 5 3 105 cells were washed with 1 ml ice-cold
BS/2% calf serum and incubated with primary antibod-
es on ice in 100 ml for 10 min. The anti-gD serum R7 was
iluted 1:500 in PBS/2% calf serum and the chicken
olyclonal anti-HveC was used at 100 mg/ml. The cells
ere washed and incubated in PBS/2% calf serum plus
econdary antibody for 10 min in 100 ml on ice. FITC-
conjugated goat anti-rabbit (Sigma) and biotinylated don-
key anti-chicken (Jackson ImmunoResearch) were di-
luted 1:200. The cells were washed and incubated in
ice-cold PBS/2% calf serum containing APC-conjugated
streptavidin (Pharmingen) at a dilution of 1:200 for 10
min. Just prior to performance of flow cytometry (Becton–
Dickinson FACS-Calibur) propidium iodide was added to
a final concentration of 1 mg/ml in PBS/2% calf serum to
xclude dead cells from analysis.
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